These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1394714)

  • 1. Dose-dependent pharmacokinetics of glycyrrhizin in rats.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1917-20. PubMed ID: 1394714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of glycyrrhetic acid, a major metabolite of glycyrrhizin, in rats.
    Ishida S; Sakiya Y; Ichikawa T; Awazu S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2509-13. PubMed ID: 2605701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of glycyrrhizin in the perfused liver of rats.
    Ishida S; Sakiya Y; Taira Z
    Biol Pharm Bull; 1994 Jul; 17(7):960-9. PubMed ID: 8000386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of glycyrrhizin by isolated rat hepatocytes.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z
    Biol Pharm Bull; 1993 Mar; 16(3):293-7. PubMed ID: 8364475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of glycyrrhizin after intravenous administration to rats.
    Tsai TH; Liao JF; Shum AY; Chen CF
    J Pharm Sci; 1992 Sep; 81(9):961-3. PubMed ID: 1432649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability.
    Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
    Biol Pharm Bull; 1995 Feb; 18(2):337-41. PubMed ID: 7742809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of glycyrrhizin disposition in rat and man with liver failure by a physiologically based pharmacokinetic model.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z; Awazu S
    J Pharmacobiodyn; 1990 Feb; 13(2):142-57. PubMed ID: 2384851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats.
    Ichikawa T; Ishida S; Sakiya Y; Sawada Y; Hanano M
    J Pharm Sci; 1986 Jul; 75(7):672-5. PubMed ID: 3761168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease.
    Wang Z; Okamoto M; Kurosaki Y; Nakayama T; Kimura T
    Biol Pharm Bull; 1996 Jun; 19(6):901-4. PubMed ID: 8799498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation.
    Kawakami J; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
    J Pharm Sci; 1993 Mar; 82(3):301-5. PubMed ID: 8450426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis.
    Takeda S; Ishthara K; Wakui Y; Amagaya S; Maruno M; Akao T; Kobashi K
    J Pharm Pharmacol; 1996 Sep; 48(9):902-5. PubMed ID: 8910850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
    Tanaka N; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Aikawa T; Osuga T; Iga T
    Biopharm Drug Dispos; 1993 Oct; 14(7):609-14. PubMed ID: 8251615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
    Takahashi M; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Shimada S; Samori T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1929-36. PubMed ID: 8558777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration.
    Kiriyama A; Fujita K; Takemura S; Kuramoto H; Kiso Y; Takada K
    Biopharm Drug Dispos; 1994 Oct; 15(7):617-26. PubMed ID: 7849237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-linear pharmacokinetics of ofloxacin after a single intravenous bolus dose in pigs.
    Son DS; Ikenoue N; Tagawa Y; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2000 Oct; 23(5):311-5. PubMed ID: 11107005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model.
    Ishida S; Sakiya Y; Ichikawa T; Taira Z; Awazu S
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):212-8. PubMed ID: 2337943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method.
    Yamamura Y; Kawakami J; Santa T; Kotaki H; Uchino K; Sawada Y; Tanaka N; Iga T
    J Pharm Sci; 1992 Oct; 81(10):1042-6. PubMed ID: 1432618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of glycyrrhizin to human serum and human serum albumin.
    Ishida S; Sakiya Y; Ichikawa T; Kinoshita M; Awazu S
    Chem Pharm Bull (Tokyo); 1989 Jan; 37(1):226-8. PubMed ID: 2720854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on concentration of glycyrrhizin in plasma and its absorption after oral administration of licorice extract and glycyrrhizin].
    Ozaki Y; Noguchi M; Kamakura H; Harada M
    Yakugaku Zasshi; 1990 Jan; 110(1):77-81. PubMed ID: 2355311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.